Literature DB >> 30141004

Tertiary Lymphoid Structures Among the World of Noncanonical Ectopic Lymphoid Organizations.

Aaron Silva-Sanchez1, Troy D Randall2, Selene Meza-Perez1.   

Abstract

Tertiary lymphoid structures (TLOs), also known as ectopic lymphoid structures, are associated with chronic infections and inflammatory diseases. Despite their association with pathology, these structures are actually a normal, albeit transient, component of the immune system and facilitate local immune responses that are meant to mitigate inflammation and resolve infection. Many of the mechanisms controlling the formation and function of tertiary lymphoid structures have been identified, in part by experimentally triggering their formation using defined stimuli under controlled conditions. Here, we introduce the experimental and pathological conditions in which tertiary lymphoid tissues are formed, describe the mechanisms linked to their formation, and discuss their functions in the context of both infection and inflammation.

Entities:  

Keywords:  Autoimmunity; B-cell follicle; Ectopic lymphoid tissue; Fibroblastic reticular cell (FRC); Follicular dendritic cell (FDC); Germinal center; Secondary lymphoid organ (SLO); Tertiary lymphoid organ (TLO)

Mesh:

Year:  2018        PMID: 30141004     DOI: 10.1007/978-1-4939-8709-2_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Characteristics and Prognostic Value of Tertiary Lymphoid Organs in Membranous Nephropathy: A Retrospective Study.

Authors:  Zu-Feng Wang; Yi-Chun Cheng; Yue-Qiang Li; Liu Liu; Shu-Wang Ge; Gang Xu
Journal:  Front Med (Lausanne)       Date:  2022-02-08

Review 2.  Tumor-Associated Tertiary Lymphoid Structures: From Basic and Clinical Knowledge to Therapeutic Manipulation.

Authors:  Charlotte Domblides; Juliette Rochefort; Clémence Riffard; Marylou Panouillot; Géraldine Lescaille; Jean-Luc Teillaud; Véronique Mateo; Marie-Caroline Dieu-Nosjean
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.